Section one: Contracting authority/entity
one.1) Name and addresses
Department of Health and Social Care
39 Victoria Street
London
SW1H 0EU
Country
United Kingdom
NUTS code
UKI32 - Westminster
Internet address(es)
Main address
https://www.gov.uk/government/organisations/department-of-health-and-social-care
Buyer's address
https://www.gov.uk/government/organisations/department-of-health-and-social-care
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Contract for the supply of live attenuated intranasal influenza vaccine
Reference number
CM/PHV/14/5433_1
two.1.2) Main CPV code
- 33651660 - Influenza vaccines
two.1.3) Type of contract
Supplies
two.1.4) Short description
Provision for a contract for the supply of live attenuated intranasal influenza vaccine
Section six. Complementary information
six.6) Original notice reference
Notice number: 2021/S 000-008707
Section seven. Changes
seven.1.2) Text to be corrected in the original notice
Section number
V.2.1.1
Place of text to be modified
Contract conclusion date
Instead of
Date
20 March 2021
Read
Date
21 March 2021
Section number
V.2.3.1
Place of text to be modified
Address of the Contractor
Instead of
Text
AstraZeneca
1 Francis Crick Avenue, Cambridge, United Kingdom, LCB2 0AA
Registration number: 3674842
Read
Text
AstraZeneca UK Limited
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA
Registration number: 03674842
Section number
IV.1.1.1
Place of text to be modified
Explanation
Instead of
Text
There is only one supplier with an exclusive global licence to manufacture and distribute this vaccine which is licensed and approved for use in the UK and due to the functions of the vaccine, there is no reasonable alternative or substitute, therefore using the negotiated procedure without prior publication is justified under Regulation 32(2)(b)(ii) and (iii) of the Public Contracts Regulations 2015.
Read
Text
DHSC is procuring these vaccines on the recommendation of the JCVI that this type of vaccine should be offered . There is only one supplier of this type of vaccine with the applicable Marketing Authorisation in the UK and, due to the functions of the vaccine, there is no reasonable alternative or substitute currently licenced for use in the UK. Competition is therefore absent for technical reasons and the use of the negotiated procedure without prior publication is justified under Regulation 32(2)(b)(ii) of the Public Contract Regulations 2015 (as amended).
Section number
II.1.1.2
Place of text to be modified
Reference number
Instead of
Text
CM/PHV/14/5433_1
Read
Text
CM/PHV/14/5433